皓元醫藥(688131.SH):密切關注DeepSeek等人工智能技術的最新進展
格隆匯2月18日丨皓元醫藥(688131.SH)近日在接待機構投資者調研時表示,近年來,隨着大數據的快速發展,人工智能作爲新一輪產業變革的核心驅動力,正在加速融入醫藥研發領域,DeepSeek的出現將推動AI技術的普及和應用,推動人工智能行業和科技行業的發展。
作爲細分行業領域具有較強影響力的企業,公司已形成覆蓋藥物研發及生產“起始物料—中間體—原料藥—製劑”的一體化,產品銷售和技術服務互相促進,客戶需求導向和自主開發相結合的獨具特色的業務模式和持續創新機制。依託強大的研發實力,公司緊跟行業科技發展前沿,積極在AI技術的融合與應用方面進行探索和實踐。一方面通過與德睿智藥、英矽智能等企業建立戰略合作,秉承“優勢互補、資源共享、合作共贏”的原則,利用AI技術幫助客戶在藥物開發過程中加快產品管線的構建,探索分子空間和佈局,以及逆合成分析合成策略,同時,基於公司強大的化合物庫資源,積極梳理並構建公司的數據積累庫,與合作夥伴共同深耕新藥研發領域,賦能生物醫藥產業蓬勃發展。此外,公司結合自身業務需求,密切關注DeepSeek等人工智能技術的最新進展,積極探索將這些技術融入商業模式和內部運營管理中,以不斷提升公司的核心競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.